Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN11 | Q06124 | 5/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | HTR2C | P28335 | 2/20 | 0.33 |
| ▸ | TACR1 | P25103 | 1/20 | 0.32 |
| ▸ | PIK3R1 | P27986 | 1/20 | 0.32 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.32 |
| ▸ | MLYCD | O95822 | 1/20 | 0.31 |
| ▸ | BCL2 | P10415 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8265891 | 0.90 | CYP1A2 (0.38) | PTPN11HSD17B10 | |
| SCHEMBL11923296 | 0.83 | PTPN11 (0.43) | PTPN11HSD17B10HTR2CTACR1PIK3R1 | |
| SCHEMBL8266187 | 0.82 | MAPT (0.37) | HSD17B10HTR2C | |
| SCHEMBL8267721 | 0.80 | PIK3R1 (0.35) | PTPN11HSD17B10HTR2CTACR1PIK3R1 | |
| SCHEMBL8267735 | 0.78 | POLB (0.36) | — | |
| SCHEMBL8267321 | 0.75 | TACR1 (0.37) | PTPN11HTR2CTACR1 | |
| SCHEMBL8267713 | 0.74 | KMT2A (0.41) | — | |
| SCHEMBL11923230 | 0.73 | PTPN11 (0.40) | PTPN11HTR2CTACR1 | |
| SCHEMBL8267763 | 0.73 | CYP1A2 (0.37) | PTPN11HSD17B10PIK3CA | |
| SCHEMBL11923180 | 0.73 | TACR1 (0.49) | PTPN11HSD17B10HTR2CTACR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2006050476-A2 | PYRIMIDINE DERIVATIVES AS ION CHANNEL MODULATORS AND METHODS OF USE | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2006-05-11 | — | — | WO | disclosed |